Cargando…

Efficacy and effectiveness of Ceftaroline Fosamil in patients with pneumonia: a systematic review and meta-analysis

BACKGROUND: Pneumonia is a relevant clinical and public health issue worldwide frequently associated with infections caused by Multi-Drug Resistant (MDR) pathogens. Ceftaroline fosamil is a promising new antibiotics with broad-spectrum bacterial activity. The aim of this systematic review and meta-a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sotgiu, Giovanni, Aliberti, Stefano, Gramegna, Andrea, Mantero, Marco, Di Pasquale, Marta, Trogu, Federica, Saderi, Laura, Blasi, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199731/ https://www.ncbi.nlm.nih.gov/pubmed/30352588 http://dx.doi.org/10.1186/s12931-018-0905-x

Ejemplares similares

Ceftaroline-fosamil: Acute eosinophilic pneumonia: case report
Publicado: (2021)

Ceftaroline Fosamil: A Brief Clinical Review
por: Shirley, Debbie-Ann T., et al.
Publicado: (2013)

Ceftaroline Fosamil for the Treatment of Community-Acquired Pneumonia: from FOCUS to CAPTURE
por: Carreno, Joseph J., et al.
Publicado: (2014)

Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in the intensive care unit
por: Maggiore, Christy, et al.
Publicado: (2015)

809 Contemporary Experience with Ceftaroline Fosamil for the Treatment of Community-acquired Bacterial Pneumonia
por: Johnson, Leonard B, et al.
Publicado: (2014)

Use of Ceftaroline Fosamil in Osteomyelitis: CAPTURE Study Experience
por: Johnson, Leonard B., et al.
Publicado: (2019)

Systematic review of ceftaroline fosamil in the management of patients with methicillin-resistant Staphylococcus aureus pneumonia
por: Torres, Antoní, et al.
Publicado: (2023)

SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity
por: Blasi, Francesco, et al.
Publicado: (2021)

Management of Acute Respiratory Failure Due to Community-Acquired Pneumonia: A Systematic Review
por: Vanoni, Nicolò Maria, et al.
Publicado: (2019)

Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia
por: Esposito, Susanna, et al.
Publicado: (2021)

Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and its Application
por: Yim, Juwon, et al.
Publicado: (2016)

A Retrospective Analysis of Probability of Target Attainment in Community-Acquired Pneumonia: Ceftaroline Fosamil Versus Comparators
por: Cristinacce, Andrew, et al.
Publicado: (2019)

Correction to: Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia
por: Esposito, Susanna, et al.
Publicado: (2021)

Ceftaroline fosamil: A novel anti-Methicillin-resistant Staphylococcus aureus cephalosporin
por: Girish, C., et al.
Publicado: (2011)

Non-Intensive Care Unit Acquired Pneumonia: A New Clinical Entity?
por: Di Pasquale, Marta, et al.
Publicado: (2016)

Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia with Ceftaroline Fosamil in a Patient with Inhalational Thermal Injury
por: Faris, Janie, et al.
Publicado: (2015)

Ceftaroline fosamil doses and breakpoints for Staphylococcus aureus in complicated skin and soft tissue infections
por: Das, Shampa, et al.
Publicado: (2019)

Ceftaroline fosamil: clinical experience after 23-month prescription in a tertiary hospital
por: Álvarez, Alicia Alonso, et al.
Publicado: (2021)

Serotypes and antibiotic susceptibility of Streptococcus pneumoniae isolated from hospitalized patients with community-acquired pneumonia in Italy
por: Di Pasquale, Marta, et al.
Publicado: (2017)

Efficacy and Safety of Ceftaroline Fosamil in Hospitalized Patients with Community-Acquired Pneumonia in China: Subset Analysis of an International Phase 3 Randomized Controlled Trial
por: Zhuo, Chao, et al.
Publicado: (2022)

Ceftaroline fosamil and treatment of acute bacterial skin and skin structure infections: CAPTURE study experience
por: Santos, Paul D, et al.
Publicado: (2013)

Role of Streptococcus pneumoniae infection in chronic obstructive pulmonary disease patients in Italy
por: Mantero, Marco, et al.
Publicado: (2017)

Ceftaroline Fosamil as an Alternative for a Severe Methicillin-resistant Staphylococcus aureus Infection: A Case Report
por: Jilani, Talha N, et al.
Publicado: (2018)

Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review
por: Amati, Francesco, et al.
Publicado: (2023)

Ceftaroline Fosamil for the Treatment of Staphylococcus aureus Bacteremia Secondary to Acute Bacterial Skin and Skin Structure Infections or Community-Acquired Bacterial Pneumonia
por: Vazquez, Jose A., et al.
Publicado: (2015)

Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study
por: Aliberti, Stefano, et al.
Publicado: (2020)

Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients
por: Aliberti, Stefano, et al.
Publicado: (2022)

Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia
por: Amati, Francesco, et al.
Publicado: (2023)

Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective
por: Gramegna, Andrea, et al.
Publicado: (2018)

Correction to: Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective
por: Gramegna, Andrea, et al.
Publicado: (2020)

Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients
por: Di Pasquale, Marta Francesca, et al.
Publicado: (2019)

Nontuberculous mycobacteria infection and pulmonary disease in bronchiectasis
por: Suska, Kseniia, et al.
Publicado: (2022)

679 Ceftaroline Fosamil (CPT-F) for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) in Obese Patients
por: Kaye, Keith, et al.
Publicado: (2014)

Pharmacokinetic and Pharmacodynamic Target Attainment in Adult and Pediatric Patients Following Administration of Ceftaroline Fosamil as a 5‐Minute Infusion
por: Riccobene, Todd A., et al.
Publicado: (2021)

Prevalence and incidence of bronchiectasis in Italy
por: Aliberti, Stefano, et al.
Publicado: (2020)

Medical thoracoscopy treatment for pleural infections: a systematic review and meta-analysis
por: Mondoni, Michele, et al.
Publicado: (2021)

1567. Pharmacokinetic/Pharmacodynamic Target Attainment in Adult and Pediatric Patients following Administration of Ceftaroline Fosamil as a 5-Minute Infusion
por: Riccobene, Todd, et al.
Publicado: (2019)

Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System
por: Torres, Antoni, et al.
Publicado: (2022)

The use of extrapolation based on modeling and simulation to support high‐dose regimens of ceftaroline fosamil in pediatric patients with complicated skin and soft‐tissue infections
por: Chan, Phylinda L.S., et al.
Publicado: (2021)

An international perspective on hospitalized patients with viral community-acquired pneumonia
por: Radovanovic, Dejan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9h2pi8sf0vbpbc7glefguao1pf